Parents are struggling to find scarce doses of Beyfortus, a monoclonal antibody that promises to drastically reduce infants' chances of serious illness from RSV.

Parents are struggling to find scarce doses of Beyfortus, a monoclonal antibody that promises to drastically reduce infants’ chances of serious illness from RSV.